Le Lézard
Classified in: Oil industry, Science and technology
Subject: PER

American Chemistry Council's (ACC) former Chief Economist and Managing Director joins ICIS as Senior Economist, Global Chemicals


HOUSTON, Oct. 22, 2021 /PRNewswire/ -- ICIS, a global source of commodity intelligence, today has announced that Dr. T. Kevin Swift, formerly the American Chemistry Council (ACC)'s Chief Economist and Managing Director, will be joining the business on 1 November as the firm's Senior Economist, Global Chemicals.

ICIS Logo

Kevin specialises in chemical industry economics and the interaction of strategy, management and economic developments. His interests specifically focus on analytics and how organisations process and analyse potential strategic futures. Kevin has extensive knowledge of the chemical and energy industries, including market research within an international context.

Kevin has about 45 years of chemical industry experience, with the last 30 spent with the ACC. His invaluable and extensive experience will add to ICIS' talent and expertise as the business continues its digital transformation and provide the intelligence required to operate effectively in rapidly changing global markets.

Alex Lidback, Vice President of Chemical Analytics at Chemical Data part of ICIS, commented: "We are delighted to welcome Kevin to our business. Kevin's renowned expertise in the chemical and economic sectors will bring a wealth of insight to our consulting and analytics work. We are pleased to have Kevin onboard and look forward to working with him as we continue to our journey to connect markets, customers and data."

Dr T. Kevin Swift added: "I am humbled to be joining ICIS at this point in my career and have the opportunity to work alongside their specialists in Chemicals is very exciting. I am aware that the team at Chemical Data and ICIS develop their analysis by thoroughly examining and surveying each of the major petroleum and petrochemical markets, providing clients with an up-to-date portfolio of the markets as well the longer-term scenarios, including sustainability strategies, along the entire supply chain. It's a great time for me to be joining the team as the business focusses in its digital evolution."

About ICIS

ICIS is a trusted source of intelligence for the global energy, chemical and fertilizer industries. We are a division of RELX, a FTSE 15 company with a market cap of $60.3bn and an employee base of over 30,000 experts across 40 countries. In 2020, ICIS acquired Chemical Data (CDI), a leading provider of US petrochemical price benchmarks, market analysis, and predictive analytics, based in Houston. The combined capabilities create a global presence and trusted intelligence in key petrochemical markets worldwide.

At ICIS, we help businesses make strategic decisions, mitigate risk, improve productivity, and capitalise on new opportunities. We make some of the world's most important markets more trusted and predictable by providing data services, thought leadership and decision tools. As a result of our unmatched global presence, we can deliver targeted connected intelligence to influence thousands of decisions across supply chains every single day. We shape the world by connecting markets to optimise the world's valuable resources. With a global team of more than 600 experts, ICIS has employees based in London, New York, Houston, Karlsruhe, Milan, Mumbai, Singapore, Guangzhou, Beijing, Shanghai, Dubai, Sao Paulo, Seoul, Tokyo, and Perth.

https://www.icis.com/explore/.

About RELX

RELX is a global provider of information-based analytics and decision tools for professional and business customers. The Group serves customers in more than 180 countries and has offices in about 40 countries. It employs over 33,000 people, of whom almost half are in North America. The shares of RELX PLC, the parent company, are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RELX.

The market capitalisation is approximately £43.7bn, ?51.8bn, $60.3bn.

Logo: http://mma.prnewswire.com/media/619935/ICIS_Logo.jpg


These press releases may also interest you

at 08:50
Sleep Cycle, the world's most popular sleep tracking application, today announced the launch of ?Forest Walk,' the first installment in a new spatial audio category designed to provide an immersive and relaxing experience for its users. Spatial audio...

at 08:49
As States consider adopting their own, potentially more rigorous "fiduciary" and "best interest"-type rules and  regulations, Decision Technologies Corporation (DTC) has announced that it has provided the North American Securities Administrators...

at 08:48
BigID, the leader in data discovery and intelligence for privacy, protection, and perspective, today introduced the first-of-its-kind data catalog integration app for Tableau, the world's leading analytics platform. Joint customers can get more value...

at 08:48
The Southern California Biomedical Council (SoCalBio) -- the trade association for bioscience and digital health professionals across Greater Los Angeles ? today announced honorees for the 2021 Innovation Awards, which will be presented during an...

at 08:46
The Demex Group, the technology company behind a first-of-its-kind platform for analyzing, pricing, and transferring climate-linked risks at scale, today announced it has raised $9 million in Series A funding led by financial services and technology...

at 08:44
Lewis Pharmaceutical Information, Inc., announces the U.S. Patent Office has granted Patent No. US 10,777,322 B2 to a patient-centric system and platform called Comprehensive Medication Analysis (CMA) (https://www.cmalpi.com). The software enables a...



News published on 22 october 2021 at 08:00 and distributed by: